Volume 18, Number 8—August 2012
Peer Reviewed Report Available Online Only
Infectious Disease Transmission during Organ and Tissue Transplantation
Table 2
Organization and website | Role |
---|---|
Food and Drug Administration | Regulates transplantation of human cells and tissues and requires Food and Drug Administration–regulated tissue establishments to investigate and report serious adverse events related to infectious disease transmission |
Organ Procurement and Transplant Network | Operated by the United Network for Organ Sharing under contract with the Health Resources and Services Administration |
Reporting mechanism for potential patient safety issues and Organ Procurement and Transplant Network policy violations | |
Organ Procurement and Transplant Network committee that compiles all potential transplantation-transmitted infection cases reported to the United Network for Organ Sharing | |
Council of State and Territorial Epidemiologists | Public health reporting and investigation of suspected transplant–transmitted notifiable diseases and illness clusters are coordinated by public health epidemiologists, as described in a 2010 position statement |
Centers for Disease Control and Prevention | Provides assistance to health departments on organ and tissue transplant–associated adverse events |
The Joint Commission | Accredits and certifies >18,000 health care organizations and programs in the United States; mandates reporting of tissue adverse patient reactions to the donor source facility |
Page created: July 11, 2012
Page updated: July 11, 2012
Page reviewed: July 11, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.